NEUROCLUES
LIVE

Serial Number

97241933

Owner

P³LAB

Attorney

Michael A. Grow

Filing Date

Jan 27, 2022

Add to watchlist:

No watchlists yet
View on USPTO

NEUROCLUES Trademark

Serial Number: 97241933 • Registration: 7245599

NEUROCLUES is a trademark filed by P³LAB on January 27, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

P³LAB (2 trademarks)

Rue du Morimont 33
Louvain-laNeuve B-1341 , BE

Entity Type: 03

Trademark Details

Filing Date

January 27, 2022

Registration Date

December 19, 2023

Published for Opposition

October 3, 2023

Goods & Services

Contact lenses; Optical enhancers, namely, optical filters; Lasers, not for medical purposes; Optical inspection apparatus for industrial use; Optical target seekers, namely, optical lens sights; Telescopic target seekers, namely, telescopic lens sights; Apparatus and instruments for physics, namely, optical reflectors, optical sensors; Optical apparatus and instruments, namely, optical sensors, optical readers; Eyewear; Optical filters; Optical glass filters; Teaching and instructional apparatus, namely, medical diagnostic simulators for use as teaching aids for brain health monitoring; Biometric identification apparatus; Imaging devices for scientific purposes, namely, nuclear medical research imaging apparatus; Telescopes; Ultramicroscopes; Glassware for use in a laboratory; Specifically adapted glassware for scientific use, namely, laboratory glassware; Optical lenses; Apparatus, instruments and cables for electricity, namely, transformers, electric meters, and electric cables; Scientific and laboratory devices for treatment using electricity, namely, electricity distribution consoles; Optical devices, enhancers and correctors, namely, optical filters, optical sensors, optical readers, optical cables; Residual light image amplifiers; Thermal imaging apparatus, other than for medical use; Stereoscopic apparatus, namely, stereoscopes; Observation instruments, namely, cameras; Downloadable and recorded software for analyzing eye movement data; Downloadable and recorded adaptive software for converting eye-tracking data; Downloadable and recorded computer software for enabling the provision of electronic transmission of eye tracking data via communications networks; Interfaces for computers; Communication interface units, namely, Computer interface boards; Downloadable graphical user interface software; Downloadable computer software for use as an application programming interface (API)

Pharmaceutical preparations for use in ophthalmology; Diagnostic preparations for medical use; Diagnostic preparations for medical purposes; Antiserums being diagnostic preparations for medical purposes; Diagnostic agents for medical use; Diagnostic agents for pharmaceutical use in treating and preventing neurological disorders and vision impairment and for brain health monitoring; Clinical diagnostic reagents for medical use; Reactants being diagnostic preparations for medical diagnosis; Pharmaceutical preparations for the treatment and prevention of neurological disorders and vision impairment and for brain health monitoring; Chemical preparations for medical purposes, namely, for the treatment and prevention of neurological disorders and vision impairment and for brain health monitoring; Dermatological pharmaceutical products; Pharmaceuticals for the treatment and prevention of neurological disorders and vision impairment and for brain health monitoring; Chemico-pharmaceutical preparations for the treatment and prevention of neurological disorders and vision impairment and for brain health monitoring; Pharmaceutical products for ophthalmological use; Topical ophthalmic anti-infective substances for the treatment of infections; Diagnostic biomarker reagents for medical purposes

Pharmaceutical advice; Medical diagnostic testing, monitoring and reporting services; Medical services; Performing diagnosis of diseases; Medical diagnostic services, namely, medical diagnostic testing, monitoring and reporting services; Ophthalmological service

Ophthalmological instruments, namely, eye testing apparatus; Therapeutic instruments for ophthalmology, namely, sensors for medical use to gather biometric data; Ophthalmological instruments, namely, Intraocular lens biometers; Pupillometers for measuring pupillary distance (PD); Pupillometers for measuring pupillary reactivity to stimulus; Ophthalmological instruments, namely, optometric instruments for measuring the diameter of ophthalmic lenses; Apparatus for the diagnosis of neurological diseases, namely, MRI apparatus for medical purposes; Lasers for medical use

Providing temporary use of on-line non-downloadable software for the management of data; Providing information about the design and development of computer software; Providing temporary use of on-line non-downloadable software for the transmission of data; Providing temporary use of on-line non-downloadable software for database management; Providing temporary use of on-line non-downloadable operating software for accessing and using a cloud computing network

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 19, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 19, 2023 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 3, 2023 NPUB
PUBLISHED FOR OPPOSITION
Oct 3, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 13, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 31, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 31, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 31, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 31, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 31, 2023 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 30, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 29, 2023 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Aug 29, 2023 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Jun 14, 2023 GNFN
FINAL REFUSAL E-MAILED
Jun 14, 2023 GNFR
FINAL REFUSAL WRITTEN
Jun 14, 2023 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
May 12, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 11, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 11, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 15, 2022 GNRN
NON-FINAL ACTION E-MAILED
Nov 15, 2022 GNRT
NON-FINAL ACTION WRITTEN
Nov 15, 2022 CNRT
ASSIGNED TO EXAMINER
Nov 8, 2022 DOCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 1, 2022 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Mar 1, 2022 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 1, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 1, 2022 REAP
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 2, 2022 NWOS
NEW APPLICATION ENTERED
Jan 31, 2022 NWAP